Morningstar

Zantac Legal Ruling Represents a Major Win for GSK and Sanofi

Despite the stocks’ bounce, we continue to view GSK and Sanofi as undervalued. Consistent with our expectations, the Multidistrict Litigation, or MDL, Zantac ruling dismissed cases claiming the drug ... read more

Alternative Funds Are Winners in 2022

Many alternative strategy funds are successfully playing defense for investors in a brutal market. For investors looking for shelter from the bear market in stocks, bond funds have not lived up to ... read more

S&P/TSX Composite Index Ends the Week 2.63% Lower at 19947.07 — Data Talk

The S&P/TSX Composite Index is down 538.59 points or 2.63% this week to 19947.07 --Largest one-week point and percentage decline since the week ending Sept. 23, 2022 --Today it is down 22.12 points or ... read more

IPC Indice de Precios Y Cotizaciones Ends the Week 1.50% Lower at 50466.25 — Data Talk

The IPC Indice de Precios Y Cotizaciones is down 768.12 points or 1.50% this week to 50466.25 --Largest one-week point and percentage decline since the week ending Sept. 30, 2022 --Largest two-week ... read more

BOVESPA Index Ends the Week 3.94% Lower at 107519.56 — Data Talk

The BOVESPA Index is down 4404.37 points or 3.94% this week to 107519.56 --Largest one-week point and percentage decline since the week ending Nov. 11, 2022 --Today it is up 270.52 points or 0.25% ... read more

STOXX Europe 50 Index Ends the Week 0.68% Lower at 3779.44 — Data Talk

The STOXX Europe 50 Index is down 26.02 points or 0.68% this week to 3779.44 --Largest one-week point and percentage decline since the week ending Sept. 23, 2022 --Today it is up 22.47 points or 0.60% ... read more

NASDAQ Composite Falls 3.99% This Week to 11004.62 — Data Talk

The NASDAQ Composite Index is down 456.88 points or 3.99% this week to 11004.62 --Largest one-week point and percentage decline since the week ending Nov. 4, 2022 --Today it is down 77.39 points or 0. read more

Consumer Price Index Seen Up 0.2% in November — Data Week Ahead

The following are forecasts for next week's U.S. data from a survey compiled by The Wall Street Journal. Write to Donna Huneke at dataweekahead@wsj.com ... read more

ADRs End Lower; AstraZeneca, British American Tobacco Trade Actively

The S&P/BNY Mellon index of American depositary receipts ticked down 0.3% to 143.03. The European index edged down 0.2% to 138.10. The Asian index retreated 0.4% to 166.40. The Latin American index ... read more

Erasca Shares Drop 30% After Pricing of $100 Million Underwritten Offering, Novartis Agreement

Shares of Erasca Inc. declined roughly 30% to $5 Friday after the clinical-stage precision oncology company priced a $100 million underwritten public offering and announced a license agreement with ... read more

Related Blogs:

Points Largest Ending Decline Percentage Underwritten Million Public License Agreement Priced Announced Offering Clinical Declined Erasca Shares Roughly Friday Oncology Precision Company Percentage Decline Million Underwritten Underwritten Public Public Offering License Agreement Company Priced Precision Oncology Declined Roughly Clinical Stage Stage Precision Oncology Company Underwritten Public Offering Million Underwritten Public Oncology Company Priced Precision Oncology Company Stage Precision Oncology





Real Time RSS Feeds | Disclaimer | Contact Us